Search Results for "Buprenorphine Lc Ms Ms Method"

01:15 EDT 28th April 2015 | BioPortfolio

Matching Channels

DNA-FISH Probes

Fluorescent in situ hybridization (FISH) is a sensitive and accurate technique that allows the detection of chromosome aberrations. In this method, a single-stranded fluorescent-labeled nucleic acid...

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Herpes simplex virus HSV 1 HSV 2 HHV 1 HHV 2

Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as Human herpes virus 1 and 2 (HHV-1 and -2), are two members of the herpes virus family that infect humans. HSV-1 and HSV-2 cause the vira...

Testicular Cancer

Testicular cancer represents only 1 per cent of all cancers in men, but it is the single biggest cause of cancer-related deaths in men aged 15-35 years in the UK. The causes of testicular cancer and...

Breast Implants - Augmentation

Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silico...

Matching News

Buprenorphine Buccal Film BEMA buprenorphine regulatory update

Avoid Buprenorphine Detox for Prescription Opioid Addiction

Patients with prescription opioid dependence are less likely to be abstinent with tapering of buprenorphine therapy than with ongoing maintenance, US researchers demonstrate. Medscape Medical News

Orexo presents new Ph III data for Zubsolv

The US subsidiary of Swedish drug developer Orexo says that, in the ISTART Phase III study, Zubsolv (buprenorphine and naloxone) sublingual tablet (CIII) demonstrated comparable patient retention in t...

Relmada begins pharmacokinetic trial for new oral formulations of buprenorphine

US-based Relmada Therapeutics has started a proof-of-concept pharmacokinetic trial with its new formulations of oral, enteric-coated buprenorphine (BuTab, or REL-1028) being developed for both chronic...

Actavis secures final US FDA approval for Buprenorphine sublingual tablets

Actavis has secured final approval from the US Food and Drug Administration (FDA) on its Abbreviated New Drug Application for Buprenorphine 2mg and 8mg sublingual tablets, the generic version of Recki...

BioDelivery to develop injectable microparticle formulation of buprenorphine with Evonik for use in opioid dependence and pain

BioDelivery Sciences International, has entered into an exclusive agreement with Evonik Corporation to develop and commercialize a proprietary, injectable microparticle formulation of buprenorphine po...

Relmada cleared for PK study with BuTab

Relmada Therapeutics (OTCQB:RLMD) has received a No Objection Letter from Health Canada to conduct the first pharmacokinetic study with novel formulations of oral, enteric-coated buprenorphine (BuTab,...

Camurus licenses Braeburn North American rights to long-acting buprenorphine CAM2038

Camurus AB licensed Braeburn Pharmaceuticals SPRL exclusive North American rights to its Phase II CAM2038 (injectable low-dose buprenorphine) for opioid addiction and pain. Braeburn also holds an opti...

Matching PubMed Articles

Supply of buprenorphine waivered physicians: The influence of state policies.

Buprenorphine, an effective opioid use disorder treatment, can be prescribed only by buprenorphine-waivered physicians. We calculated the number of buprenorphine-waivered physicians/100,000 county res...

Comparative prices of diverted buprenorphine/naloxone and buprenorphine in a UK prison setting: A cross-sectional survey of drug using prisoners.

There is evidence regarding the abuse potential of buprenorphine in prison settings. There is also emerging evidence from community settings that buprenorphine/naloxone is less amenable to abuse than ...

Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel Process.

Although numbers of physicians credentialed to prescribe buprenorphine has increased over time, many credentialed physicians may be reluctant to treat individuals with opioid use disorders due to disc...

Clinical Case Conference: Unobserved "Home" Induction Onto Buprenorphine.

Unobserved or "home" buprenorphine induction has become a common clinical practice. Patients take the initial and subsequent doses of buprenorphine after, rather than during, an office visit. This cli...

Unobserved "Home" Induction Onto Buprenorphine.

Unobserved, or "home" buprenorphine induction is common in some clinical practices. Patients take the initial and subsequent doses of buprenorphine after, rather than during, an office visit. This rev...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement